A blood-based transcriptomic signature stratifies severe Crohn's disease and defines potentially targetable therapeutic pathways
{{output}}
Introduction: Despite advances in medical therapy, many patients with Crohn's disease (CD) ultimately require surgery for disease management. Identifying the underlying molecular pathways for subgroup stratification is critical ... ...
